These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 20044059)

  • 1. Identification of immunodominant antigens of Chlamydia trachomatis using proteome microarrays.
    Molina DM; Pal S; Kayala MA; Teng A; Kim PJ; Baldi P; Felgner PL; Liang X; de la Maza LM
    Vaccine; 2010 Apr; 28(17):3014-24. PubMed ID: 20044059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of immunodominant antigens by probing a whole Chlamydia trachomatis open reading frame proteome microarray using sera from immunized mice.
    Cruz-Fisher MI; Cheng C; Sun G; Pal S; Teng A; Molina DM; Kayala MA; Vigil A; Baldi P; Felgner PL; Liang X; de la Maza LM
    Infect Immun; 2011 Jan; 79(1):246-57. PubMed ID: 20956570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteomic identification of immunodominant chlamydial antigens in a mouse model.
    Teng A; Cruz-Fisher MI; Cheng C; Pal S; Sun G; Ralli-Jain P; Molina DM; Felgner PL; Liang X; de la Maza LM
    J Proteomics; 2012 Dec; 77():176-86. PubMed ID: 22959960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mapping immunodominant antigens and H-2-linked antibody responses in mice urogenitally infected with Chlamydia muridarum.
    Zeng H; Hou S; Gong S; Dong X; Zou Q; Zhong G
    Microbes Infect; 2012 Jul; 14(7-8):659-65. PubMed ID: 22421110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A primary Chlamydia trachomatis genital infection of rhesus macaques identifies new immunodominant B-cell antigens.
    Randall A; Teng A; Liang X; Pal S; Tarantal AF; Fike J; Barry PA; de la Maza LM
    PLoS One; 2021; 16(4):e0250317. PubMed ID: 33886668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of Human-Specific Immunodominant
    Rahman KS; Darville T; Russell AN; O'Connell CM; Wiesenfeld HC; Hillier SL; Chowdhury EU; Juan YC; Kaltenboeck B
    mSphere; 2018 Aug; 3(4):. PubMed ID: 30068558
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunization with the Chlamydia trachomatis major outer membrane protein, using the outer surface protein A of Borrelia burgdorferi as an adjuvant, can induce protection against a chlamydial genital challenge.
    Pal S; Luke CJ; Barbour AG; Peterson EM; de la Maza LM
    Vaccine; 2003 Mar; 21(13-14):1455-65. PubMed ID: 12615442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of multiple genital tract infections with Chlamydia trachomatis in different strains of female mice.
    Lyons JM; Morré SA; Airo-Brown LP; Peña AS; Ito JI
    J Microbiol Immunol Infect; 2005 Dec; 38(6):383-93. PubMed ID: 16341338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunization with an acellular vaccine consisting of the outer membrane complex of Chlamydia trachomatis induces protection against a genital challenge.
    Pal S; Theodor I; Peterson EM; de la Maza LM
    Infect Immun; 1997 Aug; 65(8):3361-9. PubMed ID: 9234798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Whole genome identification of C. trachomatis immunodominant antigens after genital tract infections and effect of antibiotic treatment of pigtailed macaques.
    Patton DL; Teng A; Randall A; Liang X; Felgner PL; de la Maza LM
    J Proteomics; 2014 Aug; 108():99-109. PubMed ID: 24862987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A chlamydial type III-secreted effector protein (Tarp) is predominantly recognized by antibodies from humans infected with Chlamydia trachomatis and induces protective immunity against upper genital tract pathologies in mice.
    Wang J; Chen L; Chen F; Zhang X; Zhang Y; Baseman J; Perdue S; Yeh IT; Shain R; Holland M; Bailey R; Mabey D; Yu P; Zhong G
    Vaccine; 2009 May; 27(22):2967-80. PubMed ID: 19428908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Initial route of antigen administration alters the T-cell cytokine profile produced in response to the mouse pneumonitis biovar of Chlamydia trachomatis following genital infection.
    Kelly KA; Robinson EA; Rank RG
    Infect Immun; 1996 Dec; 64(12):4976-83. PubMed ID: 8945535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancement of the protective efficacy of a Chlamydia trachomatis recombinant vaccine by combining systemic and mucosal routes for immunization.
    Ralli-Jain P; Tifrea D; Cheng C; Pal S; de la Maza LM
    Vaccine; 2010 Nov; 28(48):7659-66. PubMed ID: 20875490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A genome-wide profiling of the humoral immune response to Chlamydia trachomatis infection reveals vaccine candidate antigens expressed in humans.
    Wang J; Zhang Y; Lu C; Lei L; Yu P; Zhong G
    J Immunol; 2010 Aug; 185(3):1670-80. PubMed ID: 20581152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibodies from women urogenitally infected with C. trachomatis predominantly recognized the plasmid protein pgp3 in a conformation-dependent manner.
    Li Z; Zhong Y; Lei L; Wu Y; Wang S; Zhong G
    BMC Microbiol; 2008 Jun; 8():90. PubMed ID: 18541036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Chlamydia trachomatis-specific Th2 clone does not provide protection against a genital infection and displays reduced trafficking to the infected genital mucosa.
    Hawkins RA; Rank RG; Kelly KA
    Infect Immun; 2002 Sep; 70(9):5132-9. PubMed ID: 12183563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Route of Vaccine Administration Influences the Impact of Fms-Like Tyrosine Kinase 3 Ligand (Flt3L) on Chlamydial-Specific Protective Immune Responses.
    Pais R; Omosun Y; Igietseme JU; Fujihashi K; Eko FO
    Front Immunol; 2019; 10():1577. PubMed ID: 31333682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specific antigens of Chlamydia pecorum and their homologues in C psittaci and C trachomatis.
    Baghian A; Kousoulas K; Truax R; Storz J
    Am J Vet Res; 1996 Dec; 57(12):1720-5. PubMed ID: 8950425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of protective immunity against Chlamydia muridarum intravaginal infection with the chlamydial immunodominant antigen macrophage infectivity potentiator.
    Lu C; Peng B; Li Z; Lei L; Li Z; Chen L; He Q; Zhong G; Wu Y
    Microbes Infect; 2013 Apr; 15(4):329-38. PubMed ID: 23416214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-12 production is required for chlamydial antigen-pulsed dendritic cells to induce protection against live Chlamydia trachomatis infection.
    Lu H; Zhong G
    Infect Immun; 1999 Apr; 67(4):1763-9. PubMed ID: 10085016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.